tirzepatide vs semaglutide dosage comparison Evaluating Dose Titration in and for Weight Loss: A Retrospective Academic Call Center Study Comparison of Semaglutide vs Tirzepatide
Description
The SURMOUNT-4 trial demonstrated that continuing treatment maintains 95% of weight loss while stopping leads to substantial regain for most individuals
In parallel, triple agonists simultaneously targeting GIP, GLP-1, and GCG receptors are also under investigation, aiming to deliver greater WL and metabolic improvements than mono- or dual-agonists
Your stomach empties slower
Both brand-name and compounded tirzepatide are dispensed in quantities calculated for weekly use
The decision to use a weight loss medication is a personal decision that requires shared decision-making between you and your clinical provider
